The classification criteria for antiphospholipid syndrome (APS) generate discussion, with a
growing impression that certain patients not fulfilling these criteria might be inadequately …

Antiphospholipid syndrome (APS) is an acquired highly prothrombotic disorder in which
thrombo-inflammatory antiphospholipid antibodies (aPL) cause thrombosis via multiple …

In this review, we discuss the recent literature regarding the prevention of preeclampsia and
aim to answer common questions that arise in the routine antenatal care of pregnant …

Objectives Patients with laboratory or clinical manifestations suggestive of antiphospholipid
syndrome (APS) but not fulfilling the classification criteria constitute a clinical challenge. This …

Objective This study aims to analyze factors related to pregnancy outcomes in women with
positive antiphospholipid antibodies and previous adverse pregnancy outcomes (APOs) …

Objective Patients with antiphospholipid syndrome (APS) have immune cell abnormalities
that remain poorly understood. This study compared primary APS (PAPS) and secondary …

Introduction: Some patients with positive antiphospholipid antibodies (aPL) have not been
included in randomized clinical trials or observational registries and, therefore, information …

The antiphospholipid syndrome (APS or Hughes Syndrome) is a systemic autoimmune
disease characterised by the presence of specific and persistent circulating antiphospholipid …

Problem To illustrate the clinical features, treatment strategy, and pregnancy outcome of
patients with obstetric antiphospholipid syndrome (OAPS), non‐criteria obstetric …

Background Preeclampsia (PE) is an important cause of maternal and perinatal mortality
worldwide. It represents 10-15% of direct maternal deaths and 99% of these deaths occur in …